Triflubazam

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Triflubazam
Triflubazam.svg
Systematic (IUPAC) name
1-methyl- 5-phenyl- 7-(trifluoromethyl)- 1H-1,5-benzodiazepine- 2,4(3H,5H)-dione
Clinical data
Legal status ?
Identifiers
CAS number 22365-40-8 YesY
ATC code None
PubChem CID 31157
ChemSpider 28907 YesY
UNII 80D8H0388T YesY
Chemical data
Formula C17H13F3N2O2 
Mol. mass 334.29
 YesY (what is this?)  (verify)

Triflubazam[1] is a drug which is a 1,5-benzodiazepine derivative, related to clobazam.[2] It has sedative and anxiolytic effects, with a long half-life and duration of action.[3][4][5]

See also[edit]

References[edit]

  1. ^ DE Patent 1934607
  2. ^ Lundbeck Institute (2003). "triflubazam". psychotropics.dk. Retrieved 17 November 2010. 
  3. ^ Itil TM, Akpinar S, Fink M: Controlled clinical and quantitative EEG studies of triflubazam (ORF 8063) in patients with anxiety syndrome. Current Therapeutic Research 1976; 19: 307-315
  4. ^ Csanalosi I, Pereira-Oran J, Case G, et al.: Triflubazam (ORF 8063), a new benzodiazepine in anxiety neurosis. Current Therapeutic Research 1977; 22: 166-171
  5. ^ Nicholson AN, Stone BM, Clarke CH. Effect of the 1,5-benzodiazepines, clobazam and triflubazam, on sleep in man. British Journal of Clinical Pharmacology. 1977 Oct;4(5):567-72.